Valuation: Cannabis Bioscience International Holdings, Inc.

Market Cap 2.35M 2.05M 1.89M 1.75M 3.33M 223M 3.38M 22.68M 8.82M 110M 8.81M 8.61M 380M P/E 2024
-9.52x
P/E 2025 -11.8x
Enterprise Value 3.35M 2.93M 2.7M 2.5M 4.75M 318M 4.82M 32.36M 12.58M 157M 12.56M 12.29M 542M EV / Sales 2024
28.9x
EV / Sales 2025 25.6x
Free-Float
41.59%
Yield 2024 *
-
Yield 2025 -
04-16 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2026 CI
02-19 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2025 CI
22/10/25 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2025 CI
06/10/25 Cannabis Bioscience International Holdings, Inc Appoints Andy Trivedi to Its Board of Directors CI
22/09/25 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Full Year Ended May 31, 2025 CI
21/09/25 Cannabis Bioscience International Holdings, Inc. Auditor Raises 'Going Concern' Doubt CI
22/04/25 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2025 CI
21/01/25 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2024 CI
06/01/25 Cannabis Bioscience International Holdings Announces Partnership with Stephen Gould for Manufacturing and Distribution of Medical Products CI
26/12/24 Cannabis Bioscience International Holdings, Inc. announced that it has received $0.075 million in funding CI
26/11/24 Cannabis Bioscience International Holdings, Inc. Appoints Charles Tamburello as Directors, Effective December 1, 2024 CI
25/11/24 Cannabis Bioscience International Holdings, Inc. Unveils the Future of Wellness with Revolutionary Anti-Aging Chip CI
21/10/24 Cannabis Bioscience International Holdings, Inc. Reports Earnings Results for the First Quarter Ended August 31, 2024 CI
1 day-33.33%
1 week-33.33%
Current month-33.33%
1 month-50.00%
3 months-60.00%
6 months-71.43%
Current year-60.00%
1 week 0
Extreme 0.00015
0
1 month 0
Extreme 0.00015
0
Current year 0
Extreme 0.00015
0
1 year 0
Extreme 0.00015
0
3 years 0
Extreme 0.00015
0
5 years 0
Extreme 0.00015
0.01
10 years 0
Extreme 0
0.27
Manager TitleAgeSince
Chief Executive Officer 70 18/12/2019
Treasurer 61 05/05/2024
Corporate Secretary 66 18/12/2019
Director TitleAgeSince
Director/Board Member 70 18/12/2019
Director/Board Member 66 18/12/2019
Director/Board Member 61 05/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
-33.33%-33.33%-50.00%-60.00% 2.35M
-0.38%+5.06%+2.76%+9.22% 49.74B
-0.23%+1.33%+421.39%+598.25% 40.49B
-1.48%+4.41%+24.17%+57.67% 34.35B
-3.16%-0.57%+22.85%-7.92% 34.75B
+1.31%-0.56%+5.12%+33.90% 26.98B
+1.42%+1.12% - - 16.58B
-4.12%-3.15%+63.24%+117.73% 15.6B
-1.73%+7.47%+105.87%+103.70% 14.27B
-3.08%-2.40%+11.96%+17.35% 13.76B
Average -4.47%+0.46%+67.48%+96.66% 24.65B
Weighted average by Cap. -1.05%+4.59%+94.04%+134.19%

Financials

2024 2025
Net sales 249K 218K 201K 186K 353K 23.62M 359K 2.41M 936K 11.66M 934K 914K 40.29M 303K 265K 244K 227K 430K 28.76M 437K 2.93M 1.14M 14.19M 1.14M 1.11M 49.06M
Net income -651K -570K -525K -487K -924K -61.82M -939K -6.3M -2.45M -30.51M -2.45M -2.39M -105M -549K -480K -443K -410K -779K -52.09M -791K -5.31M -2.06M -25.71M -2.06M -2.02M -88.85M
Net Debt 939K 822K 758K 702K 1.33M 89.15M 1.35M 9.08M 3.53M 44M 3.53M 3.45M 152M 1M 875K 807K 748K 1.42M 94.95M 1.44M 9.67M 3.76M 46.86M 3.76M 3.67M 162M
Logo Cannabis Bioscience International Holdings, Inc.
Cannabis Bioscience International Holdings, Inc. is engaged in the provision of services in therapeutic areas of clinical research. The Company provides educational systems focused on medical cannabis in the United States and Latin America, as well as worldwide through online education, services in therapeutic areas of clinical trials. Through its Alpha Research Business, based in Houston, Texas, it offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sponsors and CROs. Through the Pharmacology University Business, it provides knowledge and promotes professionalism in the worldwide cannabis industry through education in and research about the medical properties and healing virtues of this substance. It offers multilevel educational services to entrepreneurs, medical and legal professionals, cultivators, dispensary technicians, manufacturers, patients, and others who desire to participate in the cannabis industry.
Employees
2
Date Price Change Volume
07/07/26 US$0.000200 -33.33% 56,003,690
02/07/26 US$0.000300 0.00% 1,460,000
01/07/26 US$0.000300 0.00% 18,338,589
30/06/26 US$0.000300 +20.00% 520,000
  1. Stock Market
  2. Stocks
  3. CBIH Stock